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ABSTRACT 
A new biodegradable coating was developed for bioabsorbable monofilament sutures. 
Specifically, a random copolymer having 35 wt-% and 65 wt-% of lactide and 
trimethylene carbonate units showed appropriate flexibility, stickiness and degradation 
rate, as well as capability to produce a complete and uniform coating. Monofilament 
sutures of polyglycolide-b-poly(glycolide-co-trimethylene carbonate-co--caprolactone)-b-
polyglycolide were loaded with chlorhexidine (CHX) and poly(hexamethylene biguanide) 
(PHMB) to explore the possibility to achieve antimicrobial activity without adverse 
cytotoxic effects. To this end, two processes based on single drug adsorption onto the 
suture surface and incorporation into the coating copolymer were used and subsequently 
evaluated. Although the second process could be considered more complex, clear benefits 
were observed in terms of drug loading efficiency, antimicrobial effect and even lack of 
cytotoxicity. In general, drugs could be loaded in an amount leading to a clear 
bacteriostatic effect for both Gram-negative and Gram-positive bacteria without causing 
significant cytotoxicity. Release profiles of PHMB and CHX were clearly different. 
Specifically, adsorption of the drug onto the fiber surface which prevented complete 
release was detected for PHMB. This polymer had advantages derived from its high 
molecular size, which hindered penetration into cells, thus resulting in lower cytotoxicity. 
Furthermore, bacterial growth kinetics measurements and bacterial adhesion assays 
showed greater effectiveness of this polymer. 
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INTRODUCTION 
 
Adhesion and proliferation of bacteria on the surface of materials are responsible for 
severe health problems. Microorganisms can survive on appropriate materials for long 
periods of time, especially in hospital environments, developing biofilms that could be 
involved in most chronic infections [1,2], hence the current demand of bacteriostatic, 
antiseptic and bactericidal agents to prevent bacterial survival and biofilm formation [3-5]. 
Today, 23% of surgical site infections [6] are caused by Gram-positive Staphylococcus 
aureus bacteria. Specifically, its drug-resistant strain becomes highly dangerous [7] since it 
could lead to patient mortality and high costs for society [8].  
Typical bactericidal agents such as triclosan (TCS), chlorhexidine (CHX) and 
poly(hexamethylene biguanide) (PHMB) [9] have been employed to prevent bacterial 
infection. However, other natural agents like bacteriophages [10] can be considered, as 
well as industrial and clinical agents such as silver [11], quaternary ammonium groups 
[12], hydantoin compounds [13], and tetracycline antibiotics [14]. 
CHX (1,1′-hexamethylene-bis-5-(4-chlorophenyl)biguanide) (Figure 1) has a high activity 
towards microorganisms [15] as a consequence of the presence of secondary amines that 
can be protonated, and therefore positively charged under normal pH conditions [16]. 
Thus, CHX affects the stability of bacterial membranes since it can attach to their 
negatively loaded (anionic) phospholipids. Furthermore, it has been claimed that CHX 
may display an anti-inflammatory effect on neutrophil toxic products [17]. PHMB is a 
cationic oligomer having an average of 7–13 biguanide groups spaced by flexible 
hexamethylene segments (Figure 1). The high number of biguanide groups lead to a high 
effectiveness against microorganisms [18], although chemical characterization is 
difficulted for the high dispersion of oligomer sizes. 
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Sutures penetrate through the protective skin and can come in contact with microorganisms 
that grow in subcutaneous tissues such as hair follicles. Microorganisms can therefore 
attach to the suture surface, allowing biofilm formation and acting as a niche for 
subsequent infections [19-21]. Moreover, the risk of infection can be increased by an 
inflammatory response caused by the suture. These problems are very important for 
sensitive and risk applications like sutures securing a central venous catheter [21]. 
Currently, the most commonly used antimicrobial surgical suture is Coated Vicryl Plus 
Antibacterial Suture, a multifilament suture constituted by a copolymer having 90 wt-% 
of glycolide and 10 wt-% of L-lactide and TCS deposited on its surface to take profit of 
its capability to inhibit the colonization of a broad spectrum of bacteria [22]. 
Nevertheless, the incorporation of other bactericides is strongly recommended for the 
following reasons: a) The increasing resistance of bacteria to TCS caused by its massive 
use [23], and b) Safety issues concerning the bioaccumulation of TCS and its negative 
effect on immune and reproductive functions [24]. In this way, coating formulations 
based on an amphiphilic polymer, poly[(aminoethyl methacrylate)-co-(butyl 
methacrylate)] (PAMBM), have been proposed due to its higher antimicrobial activity at 
lower concentrations than that detected for TCS loaded samples [25]. 
CHX has been considered as alternative to TCS; specifically, coatings based on fatty 
acids (i.e. chlorhexidine laurate and chlorhexidine palmitate) were evaluated using 
Vicryl Plus as a reference multifilament suture [26]. High antimicrobial efficacy was 
demonstrated for up to 5 days while acceptable cytotoxic levels were determined for 11 
g/cm drug content.  
The use of coatings is essential for multifilament sutures since they have a lubricant 
effect and can diminish tissue drag and risk of infection caused by capillarity [27,28]. 
These problems are not found when monofilament sutures are employed but the use of a 
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coating may be still highly interesting if a drug is incorporated. This is studied in the 
present work using MonosynTM (i.e. polyglycolide-b-poly(glycolide-co-trimethylene 
carbonate-co--caprolactone)-b-polyglycolide (Figure 1) abbreviated as poly(GL)-b-
poly(GL-co-TMC-co-CL)-b-poly(GL)) [29] as a monofilament suture and CHX and 
PHMB as examples of bactericidal drugs with low and relatively high molecular 
weights, respectively. In addition, a new coating constituted by lactide and trimethylene 
carbonate (Figure 1) (abbreviated as poly(LA-co-TMC)) was developed according to 
the interest of this kind of copolymers for different biomedical applications [30-33]. 
Composition was selected to obtain a material with a sticky nature and a low 
degradation rate.  
The goals of the present works involve also the evaluation of which is the best way to 
load the bactericide drug (i.e. direct deposition onto the suture surface or into a coating 
copolymer), the evaluation of the most effective biguanide compound (i.e. low or high 
molecular weight samples) and finally the evaluation of the higher drug load that render 
a bactericide /bacteriostatic effect without causing cytotoxicity. 
EXPERIMENTAL SECTION 
Materials 
Lactide, trimethylene carbonate and Sn(Oct)2 were purchased from Sigma-Aldrich. 
Commercially available sutures of poly(GL)-b-poly(GL-co-TMC-co-CL)-b-poly(GL) 
(MonosynTM, USP 0 and diameter 0.35-0.399 mm) were kindly supplied by B. Braun 
Surgical, S.A. This triblock copolymer was constituted by 72, 14 and 14 wt-% of 
glycolide, trimethylene carbonate and ɛ-caprolactone units, respectively. The material 
had a middle soft segment that represents the 43 wt-% of the sample. Weight average 
molecular weight was 90,700 g/mol. 
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All solvents, chlorhexidine (CHX), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-
tetrazolium bromide (MTT) and cell culture labware were purchased from Sigma-
Aldrich (Spain). Cosmocil® (poly(hexamethylene biguanide hydrochloride), PHMB) 
was kindly provided by B. Braun Surgical S.A.  
The microbial culture was prepared with reagents and labware from Scharlab (Spain). 
Escherichia coli CECT 101 and Staphylococcus epidermidis CECT 245 bacterial strains 
were obtained from Spanish Collection of Type Culture (Valencia, Spain).  African 
green monkey kidney fibroblast-like (COS-7) and epithelial-like (VERO) cells were 
purchased from ATCC (USA). 
Polymerization 
Synthesis of the coating copolymer was carried out in tubes previously silanized with a 
silanization solution type I (Sigma-Aldrich) to prevent chemical reaction between the 
monomers and the OH groups contained in the glass. Silanization was performed during 
30 min and then tubes were washed three times with anhydrous methanol and dried for 
24 hours in a preheated oven at 120°C. Copolymers with different ratios of lactide and 
trimethylene carbonate were synthesized in order to select the composition with better 
properties to be used as a coating. 
Specifically, the selected poly(LA-co-TMC) copolymer having a theoretical 35 wt-% of 
lactide units was synthesized by bulk ring-opening polymerization of the appropriate 
mixture of lactide (LA) and trimethylene carbonate (TMC) for 48 h at 130 ºC under 
nitrogen atmosphere.  Sn(Oct)2 (0.1 mol /L solution in dry toluene) was used as a 
catalyst and the monomer/initiator (M/I) ratio was equal to 1,000. This relatively low 
ratio should enhance polycondensation and transesterification reactions and lead to a 
polymer with a random microstructure and in relatively short reaction time. When 
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polymerization was completed, the tube was cooled to room-temperature and the resulting 
copolymer was dissolved in chloroform and precipitated in methanol. The recovered 
material was washed several times with methanol, dried in vacuum. 
Measurements 
 Infrared absorption spectra were recorded in the 4000-600 cm-1 range with a Fourier 
Transform FTIR 4100 Jasco spectrometer equiped with a Specac model MKII Golden 
Gate attenuated total reflection (ATR) cell. 
1H-NMR spectra were recorded with a Bruker AMX-300 spectrometer operating at 300.1 
MHz. Chemical shifts were calibrated using tetramethylsilane as the internal standard and 
CDCl3 (δ(1H) = 7.26 ppm) and deuterated DMSO (δ(1H) = 2.50 ppm) as solvents.   
Calorimetric data were obtained by differential scanning calorimetry with a TA 
Instruments Q100 series with Tzero technology and equipped with a refrigerated cooling 
system (RCS). Experiments were conducted under a flow of dry nitrogen at a heating rate 
of 20 ºC/min with a sample weight of approximately 5 mg. Calibration was performed 
with indium.  
 
Degradation studies  
Prismatic pieces (1 × 1.5 × 0.02 cm3) were employed for hydrolytic degradation while 
films (0.5 × 0.5 × 0.2 cm3) were employed for enzymatic degradation in order to enhance 
the surface/bulk ratio. To this end, polymer samples (0.4 g) were heated at 100 ºC (i.e. 
clearly above its glass transition temperature) for 12 min by means of a hydraulic press 
equiped with heating plates and a temperature controller (Graseby Specac, Kent, 
England). Pressure was progressively increased from 1 to 4 bar. Samples were 
recovered after cooling the mold or the film to room temperature. Films were 
subsequently cut to the desired size. 
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In vitro hydrolytic degradation assays were carried in deionized water at 37 ºC, 50 ºC and 
70 ºC. Samples were kept under orbital shaking in tubes filled with 8 mL of the 
degradation medium and sodium azide (0.03 wt-%) to prevent microbial growth for 
selected exposure times. The samples were then thoroughly rinsed with distilled water, 
dried to constant weight under vacuum and stored over P4O10 before analysis. Degradation 
studies were performed in triplicated and the given data corresponded to the average 
values. 
Weight retention (Wr) of the specimens was determined by the percentage ratio of 
weight after degradation (Wd) to initial weight before degradation (W0): 
௥ܹ ൌ ௗܹ / ଴ܹ ൈ 100 (1) 
Molecular weights were estimated by size exclusion chromatography (GPC) using a 
liquid chromatograph (Shimadzu, model LC-8A) equipped with an Empower computer 
program (Waters). A PL HFIP gel column (Polymer Lab) and a refractive index detector 
(Shimadzu RID-10A) were employed. The polymer was dissolved and eluted in 
1,1,1,3,3,3-hexafluoroisopropanol containing CF3COONa (0.05 M) at a flow rate of 1 
mL/min (injected volume 100 μL, sample concentration 2.0 mg/mL). The number and 
weight average molecular weights were calculated using poly(methyl methacrylate) 
standards. 
The enzymatic studies were carried out at 37 ºC with a  porcine lipase (30–90 U/mg) 
medium and using four replicates. All samples were exposed to 1 mL of pH 7.4 
phosphate buffer containing the enzyme alongside with sodium azide (0.03 w/v-%). 
Solutions were renewed every 48 h to prevent enzymatic activity loss. Samples were 
extracted, washed and dried as indicated before.  
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Incorporation of CHX and PHMB onto uncoated and coated poly(GL)-b-poly(GL-
co-TMC-co-CL)-b-poly(GL) sutures 
Poly(GL)-b-poly(GL-co-TMC-co-CL)-b-poly(GL) monofilaments (5 cm length) were 
immersed (during 5 s) in ethanol or methanol solutions containing different percentages 
of CHX (0.1-15 w/v-%) or PHMB (0.1-6 w/v-%), respectively. After drying in hot air 
sutures were immersed in an ethyl acetate bath containing 3 w/v-% of poly(LA-co-TMC) 
when coated samples were required.  Monofilaments were finally dried and stored under 
vacuum.  
The total amount of drug loaded was determined by dissolution of the suture and the 
drug in 1,1,1,3,3,3-hexafluoroisopropanol, precipitation of polymers by addition of 
ethanol and finally by absorbance measurements by UV spectroscopy of the resulting 
solution using a Shimadzu 3600 spectrometer. Calibration curves were obtained by 
plotting the absorbance measured at 261 and 236 nm versus CHX and PHMB 
concentrations, respectively. 
Release experiments 
Controlled release measurements were performed with 5 cm length pieces of uncoated 
and coated sutures. These pieces were incubated at 37 °C in an orbital shaker at 80 rpm 
in tubes of 10 mL for 1 week. A 3:7 v/v mixture of PBS buffer and ethanol was 
employed as release media, although some experiments were also carried out in an 
ethanol medium. Drug concentration was evaluated by UV spectroscopy as above 
indicated. Samples were withdrawn from the release medium at predetermined time 
intervals. The volume was kept constant by the addition of fresh medium. All drug 
release tests were carried out using three replicates and the results were averaged. 
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Antimicrobial test 
E. coli and S. epidermidis bacteria were selected to evaluate the antimicrobial effect of 
CHX and PHMB loaded sutures. The bacteria were previously grown aerobically to 
exponential phase in broth culture (5 g/L beef extract, 5 g/L NaCl, 10 g/L tryptone, 
pH 7.2). 
Growth experiments were performed on a 24-well culture plate. 5 pieces of 1 cm length 
of uncoated and coated sutures were placed into each well. Then, 2 mL of broth culture 
containing 103 CFU was seeded on the suture samples. The cultures were incubated at 
37 °C and agitated at 160 rpm. Aliquots of 100 μl were taken at predetermined time 
intervals for absorbance measurement at 650 nm in a plate reader. Thus, turbidity was 
directly related to bacterial growth. 
Bacterial adhesion onto sutures was also determined. The culture media were aspirated 
after incubation and the material washed once with distilled water. Then, 0.5 mL of 
sterile 0.01 M sodium thiosulfate was added to each well and afterwhich the sutures 
were removed. After the addition of 1 mL of broth culture, the plate was incubated at 
37 °C and agitated at 160 rpm for 24 h. The bacterial number was determined as above 
indicated. All assays were conducted in quadriplicate and the values averaged. 
Regarding the qualitatively method, around 5 cm length pieces of loaded and unloaded 
sutures were placed into the agar diffusion plate and, seeded with 104 CFU/mL of both 
bacteria separately. The culture medium was prepared with 10.6 g of Brilliant Green Agar 
(BGA. Scharlau) or 7.9 g of Violet Red Bill Dextrose Agar (VRBDA, Scharlau) dissolved 
in 200 mL of Milli-Q water and sterilized at 121 ºC for 30 min in an autoclave. Plates were 
filled with 15 mL of medium and kept at rest to solidify the medium at room temperature. 
Inhibition halos images were taken after incubation of samples with bacteria for 24 h at 37 
ºC. 
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Cell adhesion and proliferation assays 
Studies were performed with fibroblast-like COS-7 cells and epithelial Vero cells. In all 
cases, cells were cultured in Dulbecco's modified Eagle medium (DMEM) as previously 
reported.34 
5 pieces of 1 cm length of uncoated and coated sutures were placed and fixed in each 
well of a 24-well culture plate with a small drop of silicone (Silbione® MED ADH 4300 
RTV, Bluestar Silicones France SAS, Lyon, France). This plate was then sterilized by 
UV-radiation in a laminar flux cabinet for 15 min. For the cell adhesion and 
proliferation assays, aliquots of 50–100 μL containing 2 × 105 cells were seeded onto 
the samples in each well and incubated for 24 h (adhesion assay) or 96 h (proliferation 
assay). 
Samples were evaluated by the standard adhesion and proliferation method [34]. The 
used procedure is based on a simple modification of the ISO10993-5:2009 standard test 
that describes the appropriate methodology to assess the in vitro cytotoxicity of medical 
devices. This test is designed to determine the in vitro biological response of 
mammalian cells using appropriate biological parameters. According to this ISO 
standard, devices are placed in one of three categories based on the expected contact 
with the patient: a) Limited (≤24 h), b) Prolonged (>24 h and ≤30 days) and c) 
Permanent (>30 days). In our case, the assay was performed according to both limited 
and prolonged categories. The study was carried out using four replicates and the results 
were averaged. Samples with adhered and grown cells on the samples were fixed with 
2.5 w/v-% formaldehyde at 4 °C overnight. They were subsequently dehydrated and 
processed for observation of cell morphology. 
Scanning electron microscopy (SEM) was employed to examine the morphology of coated 
and uncoated sutures as well as the morphology of adhered cells onto them. Carbon 
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coating was accomplished with a Mitec k950 Sputter Coater (fitted with a film thickness 
monitor k150x (Quorum Technologies Ltd., West Sussex, UK). SEM micrographs were 
obtained with a Zeiss Neon 40 EsB instrument (Carl Zeiss, Oberkochen, Germany). 
Statistical analysis 
Values were averaged and graphically represented, together with their respective 
standard deviations. Statistical analysis was performed by one-way ANOVA test to 
compare the means of all groups, and then Tukey's test was applied to determine a 
statistically significant difference between two groups. For it, the Origin software 
(OriginPro v.8, OriginLab Corporation, Northampton, MA, USA) was used with a test 
confidence level at 95% (p < 0.05). 
RESULTS AND DISCUSSION 
Synthesis and characterization of the coating poly(LA-co-TMC) copolymer 
The copolymer that exhibited better coating properties was that having a lactide content of 
30-35 wt-%. Other compositions rendered coatings that were too rigid and easily detached 
from the suture surface (e.g. 50 wt-% of lactide) or too sticky for proper handling of the 
suture (e.g. 20 wt-% of lactide). 
A reaction temperature of 130 ºC was enough to guarantee complete conversion of 
monomers in a reasonable time and avoid thermal degradation. The progress of the 
reaction could be easily followed from 1H NMR spectra taken from aliquots of the reaction 
mixture at regular time intervals. Thus, spectra recorded at the beginning of 
copolymerization showed signals of unreacted lactide (5.43 and 1.22 ppm) and 
trimethylene carbonate (4.43 and 1.98 ppm) monomers, which can be easily distinguished 
from those corresponding to units incorporated into the polymer chain (5.25–4.95 and 
1.61–1.52 ppm for methine and methyl protons of lactic acid units (L); 4.20–4.10 ppm for 
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the - and -methylene protons and 2.10–1.90 ppm for the -methylene protons of 
trimethylene carbonate units (TMC)) (Figure 2). Lactide reacted faster, and consequently 
polymerization time was determined by the achievement of a complete conversion of 
trimethylene carbonate, as shown in the spectrum of Figure 2 [35].  
The areas of peaks at 5.20–4.90 ppm and 4.20–4.10 ppm were used to determine the final 
composition of lactide units: 
LA (wt-%) = A5.20–4.90 × 72 / [(A5.20–4.90 × 72) + (A4.20–4.10 × 102 /4)] , (2) 
where 72 and 102 are the molecular weights of lactyl and trimethyl carbonyl units, 
respectively. 
Values were slightly lower than the theoretical monomer feed ratio due to a practically 
negligible sublimation of lactide. Thus, 32-34 wt-% was determined when the feed ratio 
corresponded to 35 wt-%.   
Sequence sensitivity was found for methine and methyl protons, and consequently 
information of chain microstructure could be derived, as previously reported [36]. 
The proton spectrum showed an intense multiplet at around 5.18 ppm, which was 
attributed to LLL and TmcLL triads, together with a quintuplet around 5.03 ppm caused 
by the overlapping of quadruplets associated with LLTmc and TmcLTmc triads. In 
addition, doublets corresponding to the LL and TmcL sequences could be detected at 
around 1.60 and 1.53 ppm, respectively, in agreement with the reported dyad sensitivity of 
CH3 protons. Note that the upfield dyad has a clearly higher intensity, indicating a high 
ratio of TmcLTmc sequences in the copolymer. This triad results from transesterification 
reactions inside the lactidyl units and should be favored by temperature, time and catalysts. 
The copolymer was obtained with a weight average molecular weight of 145,000 g/mol 
and a polydispersity index of 2.3. The FTIR spectrum was in full agreement with the 
expected chemical constitution, displaying the characteristic common bands of both 
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homopolymers (e.g. carbonyl group at 1735-1745 cm-1) as well as those only associated 
with polylactide or polytrimethylene carbonate (Figure 3) [37,38]. The main peculiar 
difference, which may be a consequence of molecular interactions, is the decrease of the 
1080 cm-1 band (i.e. symmetric C-O-C stretching) that usually appears with higher 
intensity in the PLA homopolymer.  
The DSC calorimetric trace (Figure 4) revealed the amorphous character of the copolymer 
since only a glass transition temperature of -20 ºC could be detected. This temperature was 
close to that reported for poly(trimethylene carbonate) (i.e. -25ºC [39] and -32 ºC [40]) and 
far from the value of 60 ºC for polylactide, as could be expected from the chemical 
composition. Thermal behavior was clearly different from that of the polymer matrix, 
which showed a glass transition temperature of -14 ºC and great ability to crystallize from 
the glassy state, giving rise to polyglycolide crystalline entities with a melting point close 
to 198 ºC (Figure 4). 
The copolymer was hydrolytically and enzymatically degradable, as could be inferred 
from both the sample weight (Figure 5) and molecular weight losses (Figure 6) observed 
during exposure to the different degradation media. Thus, three phases were observed for 
the pH 7 medium under the accelerated condition provided by a temperature of 70 ºC. 
Initially, the sample weight decreased very slowly, and approximately 24 days were 
required to produce a loss of 9%. After this period, a very fast weight loss was observed as 
degradation after the previous step was sufficiently advanced to render a high proportion of 
soluble molecular fragments. Specifically, weight loss increased from 9% to 83% between 
days 24 and 34. The third step was again slow because it involved highly insoluble and 
crystalline low molecular weight residues. Only the first step was detected up to 83 days, 
when degradation was performed at 50 ºC; in particular, a loss of 18% was determined. 
Practically no weight loss was detected at the physiological temperature of 37 ºC at the 
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maximum exposure time (i.e. 83 days). A low susceptibility to enzymatic degradation was 
also found since a weight loss of only 7% was determined after 61 days of exposure. 
Molecular weight changes were very useful to verify the progress of degradation. Thus, a 
steady decrease was observed in a first degradation step for hydrolytic degradation at the 
three test temperatures. This step followed a first-order kinetic which could be associated 
with a random chain scission mechanism. Obviously, the kinetic constant increased with 
temperature. In a second step, the molecular weight reached a practically constant value 
that can be interpreted as the minimum molecular size of insoluble degraded fragments. 
Thus, a molecular weight of 3,000 g/mol was attained after 24 days of exposure to the 
medium at 70 ºC, whereas 65 days were required to achieve a constant molecular weight of 
7,100 g/mol at a temperature of 50 ºC. Note that this molecular weight was slightly higher 
than that observed at 70 ºC due to the different solvent capability. 
The evolution of the polydispersity index (inset of Figure 6) was also useful to follow the 
degradation process since it reached a maximum value at the end of the first degradation 
step. After this period, samples became more homogeneous due to solubilization of small 
fragments and degradation of high molecular weight chains. 
Results pointed out a great difference between enzymatic and hydrolytic degradation under 
physiological conditions. It is obvious that hydrolytical degradation was not significant 
under these conditions and consequently small changes derived from using a distilled 
water medium which progressively becomes acid during degradation or a buffered pH 7.4 
medium could be considered negligible.   
CHX and PHMB loading of poly(GL)-b-poly(GL-co-TMC-co-CL)-b-poly(GL) 
monofilament sutures 
 
 
16 
 
The selected drugs (CHX and PHMB) had a hydrophilic character that contrasted with 
the hydrophobicity of the selected coating copolymer. Therefore, a relatively volatile 
and economical common solvent could not be used for the copolymer and the drugs. 
Ethyl acetate, ethanol and methanol were selected for coating and loading baths 
containing poly(LA-co-TMC), CHX and PHMB, respectively. Thus, the drug loading 
process involved two steps: incorporation of CHX or PHMB and coating, if necessary. 
Immersion time (5 s), drying method (hot air stream) and copolymer concentration (3 
w/v-%) were optimized to obtain the most economical and fastest process, as well as 
completely coated and uniform sutures. For example, Figure 7a shows that a higher 
copolymer concentration (e.g. 10 w/v-%) leads to formation of some aggregates on the 
monofilament surface. Drug particles can be detected on the suture surface after the first 
immersion, with these non-homogeneities being clearer for PHMB (Figure 7b). 
Nevertheless, uniform surfaces were achieved after incorporation of the coating, as shown 
in Figure 7c. 
Good correlation was observed between the drug concentration in the alcohol bath and 
the amount of loaded drug referred to the suture unit length (Figure 8). The slope of 
linear plots was 1.12 and 1.13 for CHX and PHMB, respectively, where 0.98-0.99 was 
the value of the determination coefficient (r2). These similar slopes indicated that the 
amount of incorporated drug was independent of its nature, as could be expected from 
the high chemical similarity of both biguanide compounds and the fact that the loaded 
amount should be mainly determined by the suture surface (i.e. diameter of the suture or 
USP number) [33].  
For the sake of completeness, Figure 8 also shows the correlation for uncoated samples 
(i.e. when the drug was merely adsorbed on the fiber surface after the first bath). In this 
case, the determination coefficient decreased, and specifically a value of 0.92 was  
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found for PHMB. It seems that the relatively high deviation from a perfect linear plot is 
due to an easy desorption during the manipulation of a suture lacking the protective 
coating. Note also that in the case of CHX the slope decreased to 1.00, suggesting again 
some loss of the absorbed drug during manipulation. It is, however, important to 
emphasize the protective effect of the selected coating, together with the fact that drugs 
loaded in the first bath remained adsorbed on the suture during the coating step due to 
their complete insolubility in the ethyl acetate bath. It should also be pointed out that the 
amount of loaded drug was even greater (CHX in Figure 8a) when the coating was 
employed even though the process required an additional bath.    
CHX and PHMB release from poly(GL)-b-poly(GL-co-TMC-co-CL)-b-poly(GL) 
monofilament sutures 
The release of PHMB and CHX was studied using a medium consisting of a 3:7 v/v 
mixture of PBS buffer and ethanol since it was a better solvent for the selected drugs than a 
typical nutrient serum medium. In this sense, there are previous studies that have reported 
this type of release, being Zurita et al. [33] who first pointed out this fact. It was also 
determined that physiological medium supplemented with ethanol accelerated the release 
of hydrophobic drugs and allowed performing kinetic studies in short-term experiments. 
Figure 9a compares PHMB release percentages for uncoated and coated sutures at given 
drug load (i.e. ~ 6.8 g/cm). Results clearly demonstrated the effectiveness of the coating 
to suppress the burst effect. In fact, 83% of the drug was released from the uncoated suture 
in only 5 min, while a decrease to 5% was determined when poly(LA-co-TMC) was used 
as a coating. In this case, total release was achieved after 1 h of exposure. The release was 
enhanced when 100% ethanol was used, with complete release being achieved after 45 
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min. Nevertheless, even in this case the coating was appropriate to suppress the burst 
effect.  
The release of CHX was faster, as shown by comparing the samples loaded with a similar 
amount of PHMB and CHX in Figure 9a. It can also be seen that CHX was not completely 
released. Thus, a small amount of the drug was effectively adsorbed in the suture (i.e. 16% 
(Figure 9b) for the sample loaded with ~ 5.6 g/cm, which means a value close to 0.9 
g/cm).  
Figure 9b illustrates the change in the release profiles for samples loaded with different 
amounts of CHX. All profiles showed a fast release step with a slope that slightly 
increased with concentration and a different percentage of retained drug (i.e. a plateau 
level was detected). This percentage always corresponded to an adsorption around 0.9 
g/cm. Thus, it was an intrinsic characteristic of physicochemical interactions that could 
be established between CHX and the polymer matrix. Note that the plateau observed in the 
release curves could not be associated with a solubility problem since samples loaded with 
a higher amount of CHX should have lower release percentages.  
For the sake of completeness, Figure 9b also plots the release profile of an uncoated suture. 
This sample incorporated approximately 5 g/cm of CHX, according to the loading 
relationship of Figure 8, and consequently the observed release percentage of 82% 
indicated that again 0.9 g/cm of CHX remained adsorbed on the suture surface. 
Therefore, the coating is not relevant for retaining the amount of CHX corresponding to 
the plateau, which should be mainly due to interactions with poly(GL)-b-poly(GL-co-
TMC-co-CL)-b-poly(GL).  
Antimicrobial effect of CHX and PHMB loaded poly(GL)-b-poly(GL-co-TMC-co-
CL)-b-poly(GL) monofilament sutures 
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The antimicrobial effect of CHX and PHMB loaded sutures was quantitatively 
evaluated following the growth kinetics of Gram-negative (E.coli) and Gram-positive (S. 
epidermidis) bacteria. Figure 10 shows that, for both types of bacteria, bacterial growth on 
the coated suture was always similar to that of the control. This growth was characterized 
by a lag or latency phase for a period of 4 h followed by a typical exponential growth (log 
phase). Therefore, the results showed that the coated suture was highly susceptible to 
bacterial infection. For this reason, it seemed interesting to incorporate CHX or PHMB to 
suppress this effect. Sutures loaded in baths with a drug concentration of 0.1 w/v-% 
(equivalent to a load of 0.112 g/cm and 0.113 g/cm for CHX and PHMB, respectively) 
did not have any growth inhibitory effect. In fact, concentrations of 0.3 w/v-% and 1 w/v-% 
were required for PHMB and CHX, respectively, to lead to a bacteriostatic effect. This 
effect was characterized by an increased duration of the lag phase up to 10 h and a 
subsequent linear growth instead of the typical exponential growth. The observed linear 
relationship basically indicates that bacterial growth increases as the drug is consumed. 
The bactericide effect was found for PHMB and CHX concentrations in the baths of 1.5 
w/v-% and 5 w/v-% or higher, respectively. In these cases, the latency phase was around 30 
h and the maximum growth after 48 h of culture was 20%. A completely inhibitory effect 
required a minimum CHX and PHMB concentration of 10 w/v-% and 3 w/v-%, 
respectively, which means a load of 11.2 g/cm and 3.4 g/cm.  
The behavior of uncoated CHX and PHMB loaded sutures was similar for some 
representative samples (i.e. sutures loaded with the amount corresponding to a 
bacteriostatic effect), as shown in Figure 10. In fact, a lower inhibition with respect to 
coated sutures can be explained considering that the amount of drug loaded in the bath was 
lower than expected (Figure 8), especially in the case of CHX.   
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Evaluation of bacterial adhesion was carried out as another antimicrobial control for the 
new materials (Figure 11). Results demonstrated a dose-dependent effect for both 
Gram-negative and Gram-positive bacteria. Therefore, adhesion was not inhibited for 
sutures coming from baths containing 0.1 w/v-% of drugs, while partial adhesion in the 
40%-60% range was found for sutures coming from baths containing 5 w/v-% and 0.3-1.5 
w/v-% of CHX and PHMB, respectively. Finally, complete inhibition was observed for the 
high doses corresponding to baths containing 10-15 w/v-% and 3-6 w/v-% of CHX and 
PHMB. Inhibition was higher for coated than uncoated sutures because of higher drug 
loading efficiency (Figure 8). 
The above results could also be qualitatively observed in the Agar tests by measurement of 
the inhibition halos around sutures (Figure 12). These halos are a consequence of the 
bactericidal activity which affects both inhibition of bacterial growth and bacterial 
adhesion on the suture. It should be considered that this test subestimates the effect 
produced by cationic antimicrobial compounds since they have a limited diffusion in the 
lipophilic agar medium. Nevertheless, results clearly showed that CHX and PHMB have a 
preferential effect against Gram-positive bacteria, which exhibited clearly greater 
inhibition halos than the Gram-negative medium.  
Differences in activity against Gram-positive bacteria between CHX and PHMB were 
reflected by the greater inhibition halos of CHX, probably caused by easy diffusion of 
lower molecular sizes through the agar medium. Note that an opposite behavior can be 
deduced from growth kinetic measurements, a feature that can be explained by a high 
diffusion rate for the lower molecular weight drug. Finally, the behavior of coated and 
uncoated sutures was always similar. This  demonstrates that the selected coating did not 
hinder drug diffusion from the suture to the medium, which was independent of drug size 
(small and big for CHX and PHMB, respectively).  
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Cytotoxicity of CHX and PHMB loaded poly(GL)-b-poly(GL-co-TMC-co-CL)-b-
poly(GL) monofilament sutures 
Cytotoxicity was evaluated using cell lines with a high proliferative capacity. Specifically, COS-7 
and Vero cells were selected in this study because they have well-differentiated morphologies, 
namely elongated (fibroblast-like) and polygonal (epithelial-like) shapes, respectively. These cells 
show different forms of adhesion to a material surface and provide complementary information. 
Fibroblasts can adhere by focal joints, while epithelial adhere using a wide extension of cell 
membrane. Cell adhesion and cell proliferation events after 24 and 96 h of culture, 
respectively, were analysed to determine the cytotoxicity of drug loaded sutures (Figure 
13). 
Adhesion of both cell lines was reduced in the 40% - 60% range when sutures were 
loaded with the amount of CHX that rendered a bactericidal effect and even for the 
lowest load leading to a bacteriostatic effect. Cell proliferation assays were more useful 
to discriminate between the different loads. Thus, samples coming from baths having 5 
w/v-% or higher percentages of CHX reduced cell viability drastically, whereas those 
loaded from a bath with a 1 w/v-% allowed a cell growth similar to that observed for the 
control and the unloaded suture (Figures 13e and 13f). 
On the other hand, the incorporation of PHMB reduced cell adhesion in the 20% - 40% 
range for both types of cell lines, which was practically independent of the amount of 
loaded drug (Figures 13c and 13d). Furthermore, bactericidal and bacteriostatic doses of 
PHMB caused a decrease close to 60% in the cell proliferation assays (Figures 13g and 
13h). Differences with CHX results demonstrated that a low molecular size of biguanide 
compounds had adverse effects on cell growth, as can be expected from differences in the 
ability to penetrate into the cells. The results indicated that the use of coated sutures 
favored cell adhesion and proliferation, as can be clearly seen in Figures 13d and 13g. 
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Micrographs in Figure 14 show the morphology of epithelial-like and fibroblast-like cells 
adhered to drug loaded sutures. In general, epithelial like cells appear widely extended, 
forming clusters while fibroblast-like cells appear as single, extended, well distributed 
cells.  
CONCLUSIONS 
A random copolymer prepared by ring opening polymerization of 35 wt-% of lactide and 
65 wt-% of trimethylene carbonate showed appropriate characteristics to be used as a 
coating of monofilament sutures such as the poly(GL)-b-poly(GL-co-TMC-co-CL)-b-
poly(GL) three block copolymer. The new coating was characterized by a Tg close to -20 
ºC, a low degradation rate at room temperature in a pH 7.4 medium and a solubility in 
organic media enabling a consistent and homogeneous coating to be obtained by 
immersion of sutures in an ethyl acetate bath. 
Antimicrobial drugs such as CHX and PHMB can be directly adsorbed on the suture 
surface or loaded into the suture by a two-step procedure involving a subsequent coating. 
The second method showed advantages in terms of loading efficiency as drugs were more 
protected against detachment caused by handling. Furthermore, the coating was essential 
to avoid a complete burst effect in the case of PHMB. CHX was released according to a 
first relatively fast step and at a rate slightly dependent on the amount of loaded drug. 
However, in all cases an amount close to 0.9 g/cm was retained on the suture surface, 
probably as a consequence of good interactions with the polymer matrix. The selected 
drugs exhibited a dose-dependent antimicrobial activity, and it was possible to distinguish 
between bacteriostatic and bactericidal activity. Bacterial growth kinetics and bacterial 
adhesion measurements indicated greater activity of PHMB against Gram-positive bacteria 
when samples with similar loaded weights of CHX and PHMB were compared. 
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Incorporation of the coating was not essential in terms of bactericidal activity if the effect 
of lower drug loading efficiency was discarded. 
Cell adhesion and cell proliferation assays demonstrated the potential cytotoxicity of 
sutures having high doses of CHX and PHMB, while those with a clear bacteriostatic 
effect (i.e. inhibition of bacterial growth for a period between 10 h – 30 h) could 
fortunately be considered non-cytotoxic. The presence of the coating copolymer was more 
beneficial to reduce cytotoxicity, especially when the higher molecular weight PHMB was 
employed since the molecular size influenced the rate of diffusion towards cells. 
In summary, sutures loaded with biguanide derivatives such as CHX and PHMB exhibited 
a clear preventive effect against bacterial infection or colonization while allowing cell 
adhesion and proliferation in regenerated tissues. 
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FIGURE CAPTIONS 
Figure 1. Chemical structures of poly(GL)-b-poly(GL-co-TMC-co-CL)-b-poly(GL) 
(MonosynTM), the coating poly(LA-co-TMC) copolymer and the selected CHX and 
PHMB bactericides.  
Figure 2. 1H NMR spectrum of the coating copolymer with indication of peaks associated 
with trimethylene carbonate (T) and acid lactic (L) units as labeled in the chemical 
formula. Small arrow points to the presence of a minor amount of trimethylene carbonate 
monomer for samples taken at a reaction time slightly shorter than that corresponding to a 
complete conversion.  
Figure 3. FTIR spectra (2050-650 cm-1) of PLA, PTMC and the synthesized copolymer. 
Characteristic peaks of PLA and PTMC are indicated by red and green dashed lines, 
respectively, whereas common peaks are indicated by the blue dashed lines. 
Figure 4. DSC heating traces of poly(GL)-b-poly(GL-co-TMC-co-CL)-b-poly(GL) 
(down) and the coating copolymer (up). 
Figure 5. Remaining weight percentage of poly(LA-co-TMC) coating sample exposed to a 
pH 7.4 hydrolytic degradation medium at 70 ºC (▲), 50 ºC (■) and 37 ºC (●) and a porcine 
pancreatic lipase enzymatic medium (◊). 
Figure 6. Changes in the weight average molecular weight of poly(LA-co-TMC) coating 
sample exposed to a pH 7.4 hydrolytic degradation medium at 70 ºC (▲), 50 ºC (■) and 37 
ºC (●). Changes in the polydispersity index during accelerated degradation are shown in 
the inset. 
Figure 7. Scanning electron micrographs of a monofilament of the poly(GL)-b-poly(GL-
co-TMC-co-CL)-b-poly(GL) suture with the following treatments: a) coating by 
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immersion for 5 s in an ethyl acetate bath containing 10 w/v-% of poly(LA-co-TMC), b) 
immersion  in a  methanol bath containing  3 w/v-% of PHMB and c) a first immersion in a 
methanol bath containing 3 w/v-% of PHMB and then in an ethyl acetate bath containing 3 
w/v-% of poly(LA-co-TMC) (c). 
 
Figure 8. Plot of the amount of chlorhexidine (●) and PHMB (■) incorporated into the 
poly(GL)-b-poly(GL-co-TMC-co-CL)-b-poly(GL) suture (drug weight/suture length) 
versus drug concentration of ethanol and methanol baths. Results are given for solutions 
with (solid lines) and without (dashed lines) poly(LA-co-TMC).  
Figure 9. a) PHMB release percentages in PBS-EtOH 30:70 medium for uncoated (○) and 
coated (●) sutures. For the sake of completeness, data for an EtOH medium are also 
plotted (▲) for the coated suture as well as the CHX release percentage plot in PBS-EtOH 
30:70 medium for the coated suture (■). Samples were obtained from baths containing 6 
w/v-% and 5 w/v-% of PHMB and CHX, respectively. b)  CHX release percentages in a 
PBS-EtOH 30:70 medium for coated sutures loaded in baths with 15 w/v-% (♦),10 w/v-% 
(●), 5 w/v-% (■) and 1 w/v-% (▲) of CHX. For the sake of completeness, data for an 
uncoated suture coming from a bath containing 5 w/v-% (□) of CHX are also plotted. 
Figure 10. Growth curves of E. coli (a,c) and S. epidermidis (b,d) on culture plate as 
positive control (□), coated suture as blank (◯) and poly(LA-co-TMC) coated sutures 
(dashed lines) loaded in baths with the indicated  w/v-%  of CHX (a,b) and PHMB (c,d). 
For the sake of completeness, data for uncoated sutures loaded from selected baths are also 
plotted (solid lines).  
Figure 11. Adhesion of E. coli (a,c), and S. epidermidis (b,d) bacteria on uncoated (gray 
bars) and poly(LA-co-TMC) coated (grid bars) sutures loaded in baths with the indicated 
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concentrations of CHX (a,b) and PHMB (c,d). Data concerning the culture plate as positive 
control and the coated and uncoated sutures as blank are also provided. 
Figure 12. Agar tests showing the inhibition zone of E. coli and S. epidermidis bacteria 
caused by uncoated and poly(LA-co-TMC) coated sutures loaded in baths with the 
indicated CHX and PHMB concentrations. 
Figure 13. Adhesion (a-d) and proliferation (e-h) of Vero (a,c,e,g) and COS-7 (b,d,f,h) 
cells on uncoated (gray bars) and poly(LA-co-TMC) (grid bars) coated sutures loaded in 
baths with the indicated concentrations of CHX (a,b,e,f) and PHMB (c,d,g,h). Data 
concerning the culture plate as positive control are also provided. 
Figure 14. SEM micrographs of Vero (a,b) and COS-7 (c) cell growth on poly(LA-co-
TMC) coated sutures loaded in baths with CHX (a,b) and PHMB (c) concentrations of 1 
w/v-% and 1.5 w/v-%, respectively.  
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Figure 1. Chemical structures of poly(GL)-b-poly(GL-co-TMC-co-CL)-b-poly(GL) 
(MonosynTM), the coating poly(LA-co-TMC) copolymer and the selected CHX and 
PHMB bactericides.  
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Figure 2. 1H NMR spectrum of the coating copolymer with indication of peaks associated 
with trimethylene carbonate (T) and acid lactic (L) units as labeled in the chemical 
formula. Small arrow points to the presence of a minor amount of trimethylene carbonate 
monomer for samples taken at a reaction time slightly shorter than that corresponding to a 
complete conversion.  
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Figure 3. FTIR spectra (2050-650 cm-1) of PLA, PTMC and the synthesized copolymer. 
Characteristic peaks of PLA and PTMC are indicated by red and green dashed lines, 
respectively, whereas common peaks are indicated by the blue dashed lines. 
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Figure 4. DSC heating traces of poly(GL)-b-poly(GL-co-TMC-co-CL)-b-poly(GL) 
(down) and the coating copolymer (up). 
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Figure 5. Remaining weight percentage of poly(LA-co-TMC) coating sample exposed to a 
pH 7.4 hydrolytic degradation medium at 70 ºC (▲), 50 ºC (■) and 37 ºC (●) and a porcine 
pancreatic lipase enzymatic medium (◊). 
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Figure 6. Changes in the weight average molecular weight of poly(LA-co-TMC) coating 
sample exposed to a pH 7 hydrolytic degradation medium at 70 ºC (▲), 50 ºC (■) and 37 ºC 
(●). Changes in the polydispersity index during accelerated degradation are shown in the 
inset. 
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Figure 7. Scanning electron micrographs of a monofilament of the poly(GL)-b-poly(GL-
co-TMC-co-CL)-b-poly(GL) suture with the following treatments: a) coating by 
immersion for 5 s in an ethyl acetate bath containing 10 w/v-% of poly(LA-co-TMC), b) 
immersion  in a  methanol bath containing  3 w/v-% of PHMB and c) a first immersion in a 
methanol bath containing 3 w/v-% of PHMB and then in an ethyl acetate bath containing 3 
w/v-% of poly(LA-co-TMC) (c). 
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Figure 8. Plot of the amount of chlorhexidine (●) and PHMB (■) incorporated into the 
poly(GL)-b-poly(GL-co-TMC-co-CL)-b-poly(GL) suture (drug weight/suture length) 
versus drug concentration of ethanol and methanol baths. Results are given for solutions 
with (solid lines) and without (dashed lines) poly(LA-co-TMC).  
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Figure 9. a) PHMB release percentages in PBS-EtOH 30:70 medium for uncoated (○) and 
coated (●) sutures. For the sake of completeness, data for an EtOH medium are also 
plotted (▲) for the coated suture as well as the CHX release percentage plot in PBS-EtOH 
30:70 medium for the coated suture (■). Samples were obtained from baths containing 6 
w/v-% and 5 w/v-% of PHMB and CHX, respectively. b)  CHX release percentages in a 
PBS-EtOH 30:70 medium for coated sutures loaded in baths with 15 w/v-% (♦),10 w/v-% 
(●), 5 w/v-% (■) and 1 w/v-% (▲) of CHX. For the sake of completeness, data for an 
uncoated suture coming from a bath containing 5 w/v-% (□) of CHX are also plotted. 
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Figure 10. Growth curves of E. coli (a,c) and S. epidermidis (b,d) on culture plate as 
positive control (□), coated suture as blank (◯) and poly(LA-co-TMC) coated sutures 
(dashed lines) loaded in baths with the indicated  w/v-%  of CHX (a,b) and PHMB (c,d). 
For the sake of completeness, data for uncoated sutures loaded from selected baths are also 
plotted (solid lines).  
 
 
 
 
 
  
 
 
42 
 
 
 
Figure 11. Adhesion of E. coli (a,c), and S. epidermidis (b,d) bacteria on uncoated (gray 
bars) and poly(LA-co-TMC) coated (grid bars) sutures loaded in baths with the indicated 
concentrations of CHX (a,b) and PHMB (c,d). Data concerning the culture plate as positive 
control and the coated and uncoated sutures as blank are also provided. 
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Figure 12. Agar tests showing the inhibition zone of E. coli and S. epidermidis bacteria 
caused by uncoated and poly(LA-co-TMC) coated sutures loaded in baths with the 
indicated CHX and PHMB concentrations. 
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Figure 13. Adhesion (a-d) and proliferation (e-h) of Vero (a,c,e,g) and COS-7 (b,d,f,h) 
cells on uncoated (gray bars) and poly(LA-co-TMC) (grid bars) coated sutures loaded in 
baths with the indicated concentrations of CHX (a,b,e,f) and PHMB (c,d,g,h). Data 
concerning the culture plate as positive control are also provided. 
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Figure 14. SEM micrographs of Vero (a,b) and COS-7 (c) cell growth on poly(LA-co-
TMC) coated sutures loaded in baths with CHX (a,b) and PHMB (c) concentrations of 1 
w/v-% and 1.5 w/v-%, respectively.  
 
 
 
 
 
